Related Experiment Video
Updated: Jul 27, 2026
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Targeting hypoxia tolerance in cancer.
Bradly G Wouters1, Twan van den Beucken, Michael G Magagnin
1Maastricht Radiation Oncology (Maastro) Lab, GROW Research Institute, University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands. brad.wouters@maastro.unimaas.nl
Summary
Maintaining proper oxygen levels is vital for cell survival and function. Cancer cells exploit oxygen imbalances, complicating treatment and driving malignancy, prompting research into targeting these oxygen-sensing pathways.
Area of Science:
- Physiology
- Oncology
- Cell Biology
Background:
- Tissue oxygen homeostasis is crucial for cellular functions, proliferation, and survival.
- Dysregulation of oxygen homeostasis is linked to various diseases, including cancer, heart disease, and stroke.
- Tumor microenvironments exhibit significant oxygen heterogeneity, impacting cancer progression and treatment outcomes.
Purpose of the Study:
- To explore the critical role of oxygen homeostasis in cellular functions and disease pathology.
- To investigate the implications of tumor-specific oxygen heterogeneity in cancer malignancy.
- To highlight the potential of targeting hypoxia-responsive pathways for cancer treatment.
Main Methods:
- Review of existing literature on oxygen-sensing pathways.
- Analysis of studies investigating tumor microenvironment oxygen levels.
- Examination of research on biological responses to hypoxia in cancer.
Main Results:
- Complex oxygen-sensing pathways regulate tissue oxygen homeostasis.
- Oxygen heterogeneity within and between tumors is a significant factor in cancer.
- Biological responses to hypoxia contribute to cancer malignancy and affect treatment efficacy.
Conclusions:
- Targeting cellular responses to hypoxia presents a promising therapeutic strategy for cancer.
- Understanding oxygen homeostasis is key to addressing various pathophysiological disorders.
- Further research into hypoxia-driven alterations in cancer is warranted for improved treatment strategies.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:23Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...